SPARC Intraday Analysis...

SPARC Share Price

Open 319.80 Change Price %
High 322.55 1 Day -1.85 -0.58
Low 316.65 1 Week -10.05 -3.07
Close 317.40 1 Month -5.15 -1.60
Volume 102627 1 Year 9.35 3.04
52 Week High 414.90
52 Week Low 270.00
SPARC Important Levels
Resistance 2 322.87
Resistance 1 320.62
Pivot 318.87
Support 1 314.18
Support 2 311.93
NSE INDIA Most Active Stocks
ADANIENT 114.15 -3.71%
IDFCBANK 65.20 6.54%
SUZLON 20.50 -1.68%
JSWENERGY 66.90 4.94%
GMRINFRA 17.55 2.33%
JPASSOCIAT 13.55 3.44%
IDFC 61.20 4.70%
IBREALEST 156.30 1.46%
SOUTHBANK 24.60 1.86%
SBIN 282.05 -1.54%
More..
NSE INDIA Top Gainers Stocks
LCCINFOTEC 0.25 25.00%
PETRONENGG 175.60 19.99%
FACT 47.75 17.32%
SURYAROSNI 255.80 15.25%
SASKEN 447.75 13.70%
TFL 11.55 12.14%
HEG 315.20 10.25%
HEG 315.20 10.25%
PGIL 132.65 9.40%
BHANDARI 2.95 9.26%
More..
NSE INDIA Top Losers Stocks
KSERASERA 0.15 -25.00%
VISESHINFO 0.15 -25.00%
RAJRAYON 0.20 -20.00%
SHILPI 132.75 -19.98%
NAKODA 0.40 -11.11%
SHARONBIO 7.20 -10.00%
WELINV 117.50 -8.02%
LAKSHVILAS 180.30 -7.77%
TCIDEVELOP 492.10 -7.67%
HIL 797.35 -6.18%
More..

Sun Pharma Advanced Research Company Limited (NSE: SPARC)

SPARC Technical Analysis 3
As on 27th Apr 2017 SPARC Share Price closed @ 317.40 and we RECOMMEND Sell for LONG-TERM with Stoploss of 327.22 & Sell for SHORT-TERM with Stoploss of 326.03 we also expect STOCK to react on Following IMPORTANT LEVELS.
SPARC Target for April
1st Target up-side 337.49
2nd Target up-side 352.23
3rd Target up-side 366.98
1st Target down-side 295.41
2nd Target down-side 280.67
3rd Target down-side 265.92
SPARC Synopsis Technicals View
50 Day EMA Close is Below EMA 50 (Short Term)
Bearish
100 Day EMA Close is Below EMA 100 (Mid Term) Bearish
200 Day EMA Close is Below EMA 200 (Long Term) Bearish
MACD (12 26 9) MACD Line is Less Then SIGNAL Line Bearish
RSI (14) RSI is 39.60 Sideways
MFI (14) MFI is 23.95 Sideways
CCI (20) CCI is Below -100 Over Sold
WILLIAM %R (14) William %R is Below -80 Over Sold
ADX (14) ADX is Above 20 & +DI is Above -DI Up Trend
PSAR Stoploss For Short Sell 346.24
10 Day Avg Volume Traded -38.08 % Less then 10 Day Average Volume
SPARC Other Details
Segment EQ
Market Capital 8430601728.00
Sector Healthcare
Industry Drugs - Generic
Offical website http://www.sunpharma.in
SPARC Address
SPARC
Sun Pharma Advanced Research Centre
Akota Road
Vadodara, 390020
India
Interactive Technical Analysis Chart Sun Pharma Advanced Research Company Limited ( SPARC NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Sun Pharma Advanced Research Company Limited
SPARC Business Profile
Sun Pharma Advanced Research Company Limited operates as a pharma research and drug discovery company. It develops SUN 1334H, which has completed phase II clinical studies, used in the treatment of allergic disorders, such as seasonal and perennial allergic rhinitis, urticaria, hay fever, conjunctivitis, and pruritis; and Sun K706, a novel tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia. The company also offers SUN-597, an anti-inflammatory glucocorticoid that has completed preclinical development used for the treatment of allergic rhinitis, inflammation, asthma, and other applications; and Sun 44, a prodrug of gabapentin for the treatment of epilepsy, as well as for the treatment of neuropathic pain, restless leg syndrome, and mood disorders. In addition, it provides SUN-09, a prodrug of baclofen that has completed phase I studies for the treatment of spasticity; and SUN-L731, an oral LTD4 antagonist for asthma and allergic rhinitis. Further, the company offers gastro retentive innovative device, a once-a-day delivery system for drugs; wrap matrix oral delivery system; paclitaxel injection concentrate for nanodispersion for the treatment of breast cancer; docetaxel injection concentrate for nanodispersion for non-small cell lung cancer; and octreotide depot injections for treatment of prostate cancer and acromegaly. Additionally, the company provides salmeterol and fluticasone dry powder inhaler, a pre-metered inhalation activated device for administration of inhaled steroids and bronchodilator drugs for the treatment of asthma and COPD; swollen micelle microemulsion technology, a platform technology for solubilising ophthalmic drugs with limited or no water solubility; and gel free reservoir technology used for the treatment of chronic eye ailments, such as glaucoma. Sun Pharma Advanced Research Company Limited is based in Vadodara, India.